Hemangiopericytoma and antiangiogenic therapy: Clinical benefit of antiangiogenic therapy (sorafenib and sunitinib) in relapsed Malignant Haemangioperyctoma /Solitary Fibrous Tumour

Julien Domont; Christophe Massard; Nathalie Lassau; Jean Pierre Armand; Axel Le Cesne; Jean Charles Soria

doi:10.1007/s10637-009-9249-1

Hemangiopericytoma and antiangiogenic therapy: Clinical benefit of antiangiogenic therapy (sorafenib and sunitinib) in relapsed Malignant Haemangioperyctoma /Solitary Fibrous Tumour

Julien Domont, Christophe Massard, Nathalie Lassau, Jean Pierre Armand, Axel Le Cesne, Jean Charles Soria

Résultats de recherche: Contribution à un journal › Article 'review' › Revue par des pairs

36 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	199-202
Nombre de pages	4
journal	Investigational New Drugs
Volume	28
Numéro de publication	2
Les DOIs	https://doi.org/10.1007/s10637-009-9249-1
état	Publié - 1 avr. 2010

Accès au document

10.1007/s10637-009-9249-1

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{11f00e5909de48e8817bde29147fe5cd,

title = "Hemangiopericytoma and antiangiogenic therapy: Clinical benefit of antiangiogenic therapy (sorafenib and sunitinib) in relapsed Malignant Haemangioperyctoma /Solitary Fibrous Tumour",

keywords = "Antiangiogenic, Functional imaging, Sarcoma, Sorafenib, Sunitinib",

author = "Julien Domont and Christophe Massard and Nathalie Lassau and Armand, {Jean Pierre} and {Le Cesne}, Axel and Soria, {Jean Charles}",

year = "2010",

month = apr,

day = "1",

doi = "10.1007/s10637-009-9249-1",

language = "English",

volume = "28",

pages = "199--202",

journal = "Investigational New Drugs",

issn = "0167-6997",

number = "2",

}

Hemangiopericytoma and antiangiogenic therapy: Clinical benefit of antiangiogenic therapy (sorafenib and sunitinib) in relapsed Malignant Haemangioperyctoma /Solitary Fibrous Tumour. / Domont, Julien; Massard, Christophe; Lassau, Nathalie et al.
Dans: Investigational New Drugs, Vol 28, Numéro 2, 01.04.2010, p. 199-202.

Résultats de recherche: Contribution à un journal › Article 'review' › Revue par des pairs

TY - JOUR

T1 - Hemangiopericytoma and antiangiogenic therapy

T2 - Clinical benefit of antiangiogenic therapy (sorafenib and sunitinib) in relapsed Malignant Haemangioperyctoma /Solitary Fibrous Tumour

AU - Domont, Julien

AU - Massard, Christophe

AU - Lassau, Nathalie

AU - Armand, Jean Pierre

AU - Le Cesne, Axel

AU - Soria, Jean Charles

PY - 2010/4/1

Y1 - 2010/4/1

KW - Antiangiogenic

KW - Functional imaging

KW - Sarcoma

KW - Sorafenib

KW - Sunitinib

UR - http://www.scopus.com/inward/record.url?scp=77952221960&partnerID=8YFLogxK

U2 - 10.1007/s10637-009-9249-1

DO - 10.1007/s10637-009-9249-1

M3 - Review article

C2 - 19352594

AN - SCOPUS:77952221960

SN - 0167-6997

VL - 28

SP - 199

EP - 202

JO - Investigational New Drugs

JF - Investigational New Drugs

IS - 2

ER -